Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure

American Journal of Cardiology

Volumn 106, Issue 6, 2010, Pages 830-835

  Sachdeva, Amit ^a   Horwich, Tamara B ^b   Fonarow, Gregg C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COMPARATIVE STUDY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN CONSUMPTION; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; SYSTOLIC BLOOD PRESSURE; UNIVERSITY HOSPITAL; UREA NITROGEN BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; BLOOD PRESSURE; LUNG WEDGE PRESSURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956342970     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.045     Document Type: Article

References (26)

1. L.W. Stevenson, J.H. Tillisch, M. Hamilton, M. Luu, C. Chelimsky-Fallick, J. Moriguchi, J. Kobashigawa, and J. Walden Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤20% secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 66 1990 1348 1354
2. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds Jr, and J.R. Wilson Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
3. M.R. Mehra, J. Kobashigawa, R. Starling, S. Russell, P.A. Uber, J. Parameshwar, P. Mohacsi, S. Augustine, K. Aaronson, and M. Barr Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates2006 J Heart Lung Transplant 25 2006 1024 1042
4. G.C. Fonarow, K.F. Adams Jr, W.T. Abraham, C.W. Yancy, W.J. Boscardin ADHERE Scientific Advisory Committee Study Group and Investigators Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
5. T.T. Lee, J. Chen, D.J. Cohen, and L. Tsao The association between blood pressure and mortality in patients with heart failure Am Heart J 151 2006 76 83
6. J.T. Heywood, W. Elatre, R.G. Pai, S. Fabbri, and B. Huiskes Simple clinical criteria to determine the prognosis of heart failure J Cardiovasc Pharmacol Ther 10 2005 173 180
7. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maeda, D. Fukai, M. Ohnishi, Y. Sugimoto, and M. Kinoshita Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
8. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, M. Lopatin ADHERE Scientific Advisory Committee Study Group and Investigators Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
9. G.C. Fonarow, L.W. Stevenson, J.A. Walden, N.A. Livingston, A.E. Steimle, M.A. Hamilton, J. Moriguchi, J.H. Tillisch, and M.A. Woo Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure J Am Coll Cardiol 30 1997 725 732
10. D. Mozaffarian, S.D. Anker, I. Anand, D.T. Linker, M.D. Sullivan, J.G. Cleland, P.E. Carson, A.P. Maggioni, D.L. Mann, B. Pitt, P.A. Poole-Wilson, and W.C. Levy Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398
11. M.A. Silver, A. Maisel, C.W. Yancy, P.A. McCullough, J.C. Burnett Jr, G.S. Francis, M.R. Mehra, W.F. Peacock IV, G. Fonarow, W.B. Gibler, D.A. Morrow, J. Hollander BNP Consensus Panel BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases Congest Heart Fail 10 2004 1 30
12. G.C. Fonarow, W.F. Peacock, T.B. Horwich, C.O. Phillips, M.M. Givertz, M. Lopatin, J. Wynne ADHERE Scientific Advisory Committee, Study Group, and Investigators Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE Am J Cardiol 101 2008 231 237
13. W.H. Tang, G.S. Francis, D.A. Morrow, L.K. Newby, C.P. Cannon, R.L. Jesse, A.B. Storrow, R.H. Christenson, F.S. Apple, J. Ravkilde, A.H. Wu National Academy of Clinical Biochemistry Laboratory Medicine National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure Circulation 116 2007 e99 e109
14. J.A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625 634
15. R.S. Gardner, F. Ozalp, A.J. Murday, S.D. Robb, and T.A. McDonagh N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
16. T. Kubozono, H. Itoh, K. Oikawa, A. Tajima, T. Maeda, T. Aizawa, H. Iinuma, Y. Tokuda, Y. Ohashi, and L.T. Fu Peak VO(2) is more potent than B-type natriuretic peptide as a prognostic parameter in cardiac patients Circ J 72 2008 575 581
17. L.R. Peterson, K.B. Schechtman, G.A. Ewald, E.M. Geltman, L. de las Fuentes, T. Meyer, P. Krekeler, M.L. Moore, and J.G. Rogers Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers J Heart Lung Transplant 22 2003 1141 1148
18. D. Ramos-Barbn, D. Fitchett, W.J. Gibbons, D.A. Latter, and R.D. Levy Maximal exercise testing for the selection of heart transplantation candidates: limitation of peak oxygen consumption Chest 115 1999 410 417
19. C.A. Cauthen, M.J. Lipinski, A. Abbate, D. Appleton, A. Nusca, A. Varma, E. Goudreau, M.J. Cowley, and G.W. Vetrovec Relation of blood urea nitrogen to long-term mortality in patients with heart failure Am J Cardiol 101 2008 1643 1647
20. H.J. Lin, C.L. Chao, K.L. Chien, Y.L. Ho, C.M. Lee, Y.H. Lin, Y.W. Wu, R.B. Hsu, N.K. Chou, S.S. Wang, C.Y. Chen, and M.F. Chen Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure Clin Res Cardiol 98 2009 487 492
21. J.L. Rouleau, E.B. Roecker, M. Tendera, P. Mohacsi, H. Krum, H.A. Katus, M.B. Fowler, A.J. Coats, A. Castaigne, A. Scherhag, T.L. Holcslaw, M. Packer Carvedilol Prospective Randomized Cumulative Survival Study Group Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study J Am Coll Cardiol 43 2004 1423 1429
22. W.T. Abraham, G.C. Fonarow, N.M. Albert, W.G. Stough, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C.W. Yancy, J.B. Young OPTIMIZE-HF Investigators and Coordinators Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 52 2008 347 356
23. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
24. R.S. Gardner, G. Henderson, and T.A. McDonagh The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? J Heart Lung Transplant 24 2005 303 309
25. C. Binanay, R.M. Califf, V. Hasselblad, C.M. O'Connor, M.R. Shah, G. Sopko, L.W. Stevenson, G.S. Francis, C.V. Leier, L.W. Miller ESCAPE Investigators and ESCAPE Study Coordinators Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial JAMA 294 2005 1625 1633
26. L.A. Allen, J.E. Yager, M.J. Funk, W.C. Levy, J.A. Tulsky, M.T. Bowers, G.C. Dodson, C.M. O'Connor, and G.M. Felker Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure JAMA 299 2008 2533 2542